title: Risk stratifying retinal breaks.
abstract: OBJECTIVE
  Argon laser retinopexy has been the primary treatment for retinal breaks for many decades. Prevention of progression to retinal detachment (RD) is the main objective. The benefit of laser retinopexy is well documented, although little has been reported on the risk factors for progression to RD. By addressing this issue, patients at high risk can be identified, and more timely specialist retinal input can be sought.
  
  
  METHODS
  Data over a 6-month period from 45 consecutive patients undergoing laser retinopexy were reviewed. Patients were categorized into complete success (no more than 1 laser treatment), qualified success (no more than 3 laser or cryotherapy treatments), and treatment failure (more than 3 laser or cryotherapy treatments or progression to RD).
  
  
  RESULTS
  Complete success was observed in 53.5% of patients, a further 34.9% of patients achieved a qualified success, and the remainder of the patients (11.6%) fell into the treatment failure category. About 9.3% of patients required cryotherapy, and 7.0% of patients underwent RD surgery. Patients with a bridging blood vessel and vitreous hemorrhage were significantly more likely to be in the treatment failure category than those without. RD was significantly associated with the presence of vitreous hemorrhage.
  
  
  CONCLUSIONS
  Patients with retinal breaks associated with bridging blood vessels and vitreous hemorrhage are at greater risk for poorer outcome. The area of subretinal fluid was not linked to failure. If complete laser of a tear is not possible or if concerns remain regarding treatment efficacy, prompt referral to a retina specialist for further management is recommended.
authors: Princess Alexandra Eye Pavilion, Edinburgh, United Kingdom. Electronic address: Ashraf.khan@nhs.net.
authors: Ashraf A
authors: AA
authors: Khan
authors: Abha
authors: A
authors: Gupta
authors: Harry
authors: H
authors: Bennett
mesh_terms: D017679:Cryotherapy; D018450:Disease Progression; D006801:Humans; D017075:Laser Coagulation; D054018:Lasers, Excimer / Q000627:therapeutic use*; D012163:Retinal Detachment / Q000175:diagnosis / Q000503:physiopathology / Q000517:prevention & control; D012167:Retinal Perforations / Q000503:physiopathology / Q000601:surgery*; D012171:Retinal Vessels / Q000473:pathology; D012307:Risk Factors; D016896:Treatment Outcome; D014823:Vitreous Hemorrhage / Q000175:diagnosis / Q000503:physiopathology